Literature DB >> 23327063

Factors affecting response of chemotherapy in women with ovarian cancer.

J Lubin1, A Markowska, P Knapp.   

Abstract

Chemotherapy plays an important role in the treatment of ovarian cancer. Patients' response to chemotherapy is determined by a variety of acknowledged factors, but one might expect that many of them are yet to be described. The aim of this paper was to present the most essential yet still to be generally assessed in clinical practice, factors, which include: E-cadhedrin, hypoxia inducible factor alpha, survivin, COX-2, clusterin, BRCA1 protein, TP53 protein, YY1 protein, multidrug resistance protein, and interleukin-8.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23327063

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.

Authors:  Zhe Liu; Ruixia Du; Jin Long; Kejian Guo; Chunlin Ge; Shulong Bi; Yuanhong Xu
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

2.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

3.  Molecular mechanism of increased sensitivity of cisplatin to ovarian cancer by inhibition of microRNA-23a expression.

Authors:  Ai-Hong Jin; Zhao-Lian Wei
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.

Authors:  Hongyi Liu; Peng Li; Bing Li; Peng Sun; Jiajin Zhang; Baishi Wang; Baoqing Jia
Journal:  Tumour Biol       Date:  2014-12-30

5.  miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.

Authors:  Weiguo Cao; Weiping Yang; Rong Fan; Hao Li; Jinsong Jiang; Mei Geng; Yening Jin; Yunlin Wu
Journal:  Tumour Biol       Date:  2013-09-26

Review 6.  Clusterin: a key player in cancer chemoresistance and its inhibition.

Authors:  Tomas Koltai
Journal:  Onco Targets Ther       Date:  2014-03-20       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.